Topical nepafenac formulations

1. A topically administrable ophthalmic composition consisting of

a) 0.1% (w/v) nepafenac;

b) 0.5% (w/v) carbomer;

c) 0.001-0.05% (w/v) tyloxapol;

d) 0.3-0.5% (w/v) sodium chloride;

e) 2-3% (w/v) mannitol;

f) a pH-adjusting agent in an amount sufficient to cause the composition to have a pH from 7.3-7.7;

g) 0.001-0.01% (w/v) benzalkonium chloride;

h) 0.001-0.1% (w/v) edetate disodium; and

i) water.